Internal Reference Number: FOI_8368
Date Request Received: 08/01/2025 00:00:00
Date Request Replied To: 22/01/2025 00:00:00
This response was sent via: By Email
Request Summary: Biologics (Dermatology)
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Apremilast • Bimekizumab • Brodalumab • Certolizumab • Deucravacitinib • Dimethyl fumarate • Etanercept - Enbrel • Etanercept Biosimilar • Guselkumab • Infliximab - Remicade • Infliximab Biosimilar • Ixekizumab • Risankizumab • Secukinumab • Tildrakizumab • Ustekinumab • Ustekinumab Biosimilar • Omalizumab | |
| Answer To Question 1: • Adalimumab – Humira <5 • Adalimumab Biosimilar 33 • Apremilast <5 • Bimekizumab 7 • Brodalumab 6 • Certolizumab <5 • Deucravacitinib <5 • Dimethyl fumarate 0 • Etanercept – Enbrel 0 • Etanercept Biosimilar 0 • Guselkumab 30 • Infliximab – Remicade 0 • Infliximab Biosimilar 0 • Ixekizumab 10 • Risankizumab 9 • Secukinumab <5 • Tildrakizumab 7 • Ustekinumab 0 • Ustekinumab Biosimilar 13 • Omalizumab 7 | |
| Question Number 2: How many patients were treated in the last 3 months by the Dermatology department for HS (Hidradenitis Suppurativa) ONLY with the following: • Adalimumab - Humira • Adalimumab Biosimilar • Bimekizumab • Certolizumab • Infliximab - Remicade • Infliximab Biosimilar • Secukinumab • Ustekinumab • Ustekinumab Biosimilar | |
| Answer To Question 2: • Adalimumab – Humira 0 • Adalimumab Biosimilar <5 • Bimekizumab 0 • Certolizumab 0 • Infliximab – Remicade 0 • Infliximab Biosimilar 0 • Secukinumab 0 • Ustekinumab 0 • Ustekinumab Biosimilar 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
